Ildong Holdings Co., Ltd. (KRX:000230)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,020.00
-130.00 (-2.11%)
Last updated: Jun 24, 2026, 2:46 PM KST
Market Cap69.45B -9.3%
Revenue (ttm)598.69B -3.2%
Net Income17.11B -73.4%
EPS1,504.85 -70.9%
Shares Out 11.29M
PE Ratio4.52
Forward PEn/a
Dividend100.00 (1.53%)
Ex-Dividend DateMar 30, 2026
Volume68,264
Open6,100.00
Previous Close6,150.00
Day's Range5,700.00 - 6,200.00
52-Week Range5,700.00 - 17,170.00
Beta0.18
Analystsn/a
Price Targetn/a
Earnings DateJul 30, 2026

About Ildong Holdings

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, ... [Read more]

Sector Healthcare
Founded 1941
Employees 72
Stock Exchange Korea Stock Exchange
Ticker Symbol 000230
Full Company Profile

Financial Performance

In 2025, Ildong Holdings's revenue was 590.89 billion, a decrease of -6.90% compared to the previous year's 634.65 billion. Earnings were 10.93 billion, a decrease of -82.67%.

Financial Statements